Panacea Acquisition Corp. , a blank check company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Nuvation Bio stock last closed at $2.60, up 0.39% from the previous day, and has increased 63.52% in one year. It has overperformed other stocks in the Biotechnology industry by 0.96 percentage points. Nuvation Bio stock is currently +81.82% from its 52-week low of $1.43, and -37.5% from its 52-week high of $4.16.
At the moment, there are 336.57M shares of NUVB outstanding. The market capitalization of NUVB is $875.07M. In the last 24 hours, 2.89M NUVB shares were traded.
You need a brokerage account in order to access the NYSE market and buy NUVB shares.
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal info so you are able to invest in NUVB today.
Now that you have finished signing up on our top ranked stock trading app, you need to deposit funds:
Check out the tutorial below to see the process of transferring funds into your new brokerage account.
Once you have figured out the best place to buy Nuvation Bio stock, it's important to evaluate their stock prior to buying, so you truly comprehend the risk and upside.
WallStreetZen was created to help average investors perform more accurate fundamental analysis.
You can see all of the due diligence checks on NUVB's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge NUVB's intrinsic value.
Using relative valuations ratios:
You can access additional valuation analysis on NUVB's stock here.
Out of 3 Equities analysts who track NUVB, the consensus analyst rating on NUVB is a Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Nuvation Bio stock forecast page.
Over the past 12 months, insiders at NUVB have bought more shares than they have sold.
Junyuan Jerry Wang, CEO ANHEART THERAPEUTICS LTD. of NUVB, was the latest NUVB insider to sell. They sold $162,883.29 worth of NUVB stock on Nov 11, 2024.
Dig into more about who owns NUVB shares here.
No, Nuvation Bio doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two primary types of orders:
Press the Open button and eToro will place your order.
If you need more help buying stocks on eToro, watch the how to video below:
Now that you own some NUVB shares, you'll want to keep up with your company.
Create a watchlist to get alerted to the latest events about your NUVB stock.
To reiterate, here are the 6 steps to buy stock in Nuvation Bio:
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to watch your new investment in Nuvation Bio, get started below.